| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 08/01/2013 | US20130197017 Combinations comprising a protein kinase inhibitor being a pyrimidylaminobenzamide compound and a hsp90 inhibitor such as 17-11g |
| 08/01/2013 | US20130197015 Novel method to improve the safety and efficacy of caffeine |
| 08/01/2013 | US20130197012 Compounds for the Treatment of Hepatitis C |
| 08/01/2013 | US20130197003 Methods and compositions for treating or preventing erythema |
| 08/01/2013 | US20130196995 Combination of brimonidine and timolol for topical ophthalmic use |
| 08/01/2013 | US20130196992 1',3'-disubstituted-4-pheny-3,4,5,6-tetrahydro-2h,1'h-[1,4']bipyridinyl-2'-ones |
| 08/01/2013 | US20130196986 Triazolopyrazinones as p2x7 receptor antagonists |
| 08/01/2013 | US20130196966 Sphingosine 1 phosphate receptor modulators and methods of chiral synthesis |
| 08/01/2013 | US20130196964 Heterocyclically substituted aryl compounds as hif inhibitors |
| 08/01/2013 | US20130196962 Non-hormonal steroid modulators of nf-kb for treatment of disease |
| 08/01/2013 | US20130196961 Combinations comprising antimuscarinic agents and corticosteroids |
| 08/01/2013 | US20130196960 Cannabinoid Receptor Agonists |
| 08/01/2013 | US20130196956 Extended-release formulation for reducing the frequency of urination and method of use thereof |
| 08/01/2013 | US20130196951 Use of nitric oxide to enhance the efficacy of silver and other topical wound care agents |
| 08/01/2013 | US20130196949 Hydroxyalkyl starch in combination with cytostatica for the treatment of cancers by reduction of tumor growth rates |
| 08/01/2013 | US20130196946 Cyclodextrin-based polymers for therapeutic delivery |
| 08/01/2013 | US20130196938 Combination comprising cndac (2'-cyano-2'-deoxy-n4-palmitoyl-1-beta-d-arabinofuranosyl-cytosine) and a cytotoxic agent |
| 08/01/2013 | US20130196935 Synthetic glycoamine compounds |
| 08/01/2013 | US20130196930 Polynucleotides encoding recombinant lubricin molecules and uses thereof |
| 08/01/2013 | US20130196929 Secreted protein acidic and rich in cysteine (sparc) as chemotherapeutic sensitizers |
| 08/01/2013 | US20130196925 Compositions and methods useful in enhancement of memory |
| 08/01/2013 | US20130196921 Methods for the prevention or treatment of no-reflow following ischemia/reperfusion injury |
| 08/01/2013 | US20130196908 Methods for treatment of pain |
| 08/01/2013 | US20130196904 Pharmaceutical composition for treating medical conditions and a method for treating alimentary disorders and related diseases |
| 08/01/2013 | US20130196900 Enhancement of innate resistance to infection |
| 08/01/2013 | US20130196896 Car peptide for homing, diagnosis & targeted therapy for pulmonary and fibrotic disorders |
| 08/01/2013 | US20130196012 Extended-release formulation for reducing the frequency of urination and method of use thereof |
| 08/01/2013 | US20130196009 Anti-inflammatory and antioxidant composition and related method of use |
| 08/01/2013 | US20130196005 Use of salvia miltiorrhiza composition in preparing drugs for secondary prevention of coronary heart disease |
| 08/01/2013 | US20130196002 Inhibitors of catechol o-methyl transferase and their use in the treatment of psychotic disorders |
| 08/01/2013 | US20130195944 Method and therapeutic/cosmetic topical compositions for the treatment of rosacea and skin erythema using a1-adrenoceptor agonists |
| 08/01/2013 | US20130195943 Method and therapeutic/cosmetic topical compositions for the treatment of rosacea and skin erythema using a1-adrenoceptor agonists |
| 08/01/2013 | US20130195925 Anti aging application and method for treating aging |
| 08/01/2013 | US20130195893 Use of a pneumococcal p4 peptide for enhancing opsonophagocytosis in response to a pathogen |
| 08/01/2013 | US20130195891 Micro-RNA family that Modulates Fibrosis and Uses Thereof |
| 08/01/2013 | US20130195889 Trabeculectomy outcome |
| 08/01/2013 | US20130195887 Pharmacological vitreolysis |
| 08/01/2013 | US20130195886 Methods for Fructanase and Fructokinase Inhibition |
| 08/01/2013 | US20130195884 Novel modulators of trail signalling |
| 08/01/2013 | US20130195881 Potent, stable and non-immunosuppressive anti-cd4 antibodies |
| 08/01/2013 | US20130195879 Oxadiazole inhibitors of leukotriene production for combination therapy |
| 08/01/2013 | US20130195875 Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or an anti-adm non-ig scaffold for use in therapy |
| 08/01/2013 | US20130195874 Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for reducing the risk of mortality in a patient having a chronic or acute disease or acute condition |
| 08/01/2013 | US20130195871 Dual variable domain immunoglobulins and uses thereof |
| 08/01/2013 | US20130195858 Treatment of b-cell lymphoma with microrna |
| 08/01/2013 | US20130195857 Blood plasma biomarkers for bevacizumab combination therapies for treatment of pancreatic cancer |
| 08/01/2013 | US20130195856 Methods of altering bone growth by administration of sost or wise antagonist or agonist |
| 08/01/2013 | US20130195852 Use of inhibitors of bruton's tyrosine kinase (btk) |
| 08/01/2013 | US20130195848 Imidazopyrazines |
| 08/01/2013 | US20130195847 Treatment with anti-vegf antibodies |
| 08/01/2013 | US20130195842 Methods for treating disorders of amino acid metabolism |
| 08/01/2013 | US20130195837 Methods for the prevention or treatment of vessel occlusion injury |
| 08/01/2013 | US20130195834 Treatment of glycogen storage disease type ii |
| 08/01/2013 | US20130195824 Methods for Reducing Cholesteron Using Bacillus Coagulans Spores, Systems and Compositions |
| 08/01/2013 | US20130195817 Methods and compositions for modulating angiogenesis and vasculogenesis |
| 08/01/2013 | US20130195796 Inhibitors and Methods of Inhibiting Bacterial and Viral Pathogens |
| 08/01/2013 | US20130195763 Methods and compositions for improving sleep and memory |
| 08/01/2013 | US20130195754 IL-l BINDING PROTEINS |
| 08/01/2013 | CA2862532A1 New pharmaceutical compositions containing phosphatidylserine and curcumin |
| 07/31/2013 | EP2620160A1 Composition for oral use |
| 07/31/2013 | EP2620149A2 Use of dimiracetam in the treatment of chronic pain |
| 07/31/2013 | EP2620145A2 2,5-dihydroxybenzene compounds for the treatment of of cancer of an organ |
| 07/31/2013 | EP2620144A1 Staining Composition |
| 07/31/2013 | EP2618823A1 Xenon-based anesthetic gas composition usable during an endarterectomy involving the clamping of the carotid artery |
| 07/31/2013 | EP2618685A2 Trivalent chromium and boron fortifying composition, a hydration supplement, and process for preparing the same |
| 07/31/2013 | CN103228673A Anti-human trop- antibody having antitumor activity in vivo |
| 07/31/2013 | CN103228278A Combination therapy for treating hcv infection |
| 07/31/2013 | CN103224496A Tricyclic PI3K and/or mTOR inhibitors |
| 07/31/2013 | CN103223173A Capsule polyurethane drug controlled release body with temperature control switch, and preparation method thereof |
| 07/31/2013 | CN103223172A Medicine used for preventing and treating postmenopausal osteoporosis |
| 07/31/2013 | CN103222950A Modified amylase-based nanometer helical oil phase-triggered quick-release material and preparation method thereof |
| 07/31/2013 | CN102335430B Compound pharmaceutical composition containing midazolam and neuro protective agent |
| 07/31/2013 | CN101443017B Medication against breast cancer and related diseases |
| 07/30/2013 | CA2678008C Methods of treating a secondary bone tumor with anti-pdgfralpha antibodies |
| 07/30/2013 | CA2537300C Treatment of asprin resistance with radix salviae miltiorrhizae, its extract and composition |
| 07/30/2013 | CA2483917C Formulations limiting spread of pulmonary infections |
| 07/30/2013 | CA2451874C Antisense oligonucleotides which can inhibit the formation of capillary tubes by endothelial cells |
| 07/30/2013 | CA2425174C Human gene critical to fertility |
| 07/25/2013 | WO2013109876A1 Enhanced glycemic control using ad36e4orf1 and akt1 inhibitor |
| 07/25/2013 | WO2013109218A1 Dry powder formulations comprising carmoterol and ciclesonide |
| 07/25/2013 | WO2013109199A1 Effervescent pharmaceutical formulations comprising pregabalin and vitamin b12 |
| 07/25/2013 | WO2013109142A1 Combined pdk and mapk/erk pathway inhibition in neoplasia |
| 07/25/2013 | WO2013108869A1 Therapeutic or prophylactic agent for cancer |
| 07/25/2013 | WO2013107883A1 Tetrahydrofolates in combination with egfr-inhibitors |
| 07/25/2013 | WO2013042140A4 Non antibiotic, non peptide compounds for antibiotic efficacy & safety enhancement |
| 07/25/2013 | WO2012162777A9 Oral pharmaceutical composition comprising a proton pump inhibitor and a prokinetic agent that can be used in excess stomach acid disorders |
| 07/25/2013 | WO2012022677A3 Combination therapy for the treatment of cancer |
| 07/25/2013 | US20130190405 Methods and use of compounds that bind to her2/neu receptor complex |
| 07/25/2013 | US20130190396 Novel sulfonamide compounds for inhibition of metastatic tumor growth |
| 07/25/2013 | US20130190381 Inhibitors of long and very long chain fatty acid metabolism as broad spectrum anti-virals |
| 07/25/2013 | US20130190373 Angiotensin ii receptor antagonist for the prevention or treatment of systemic diseases in cats |
| 07/25/2013 | US20130190370 Novel Tetrahydronaphalene Antagonists to the Thromboxane A2 (TP) Receptor |
| 07/25/2013 | US20130190351 Bicyclic amides for enhancing glutamatergic synaptic responses |
| 07/25/2013 | US20130190334 N1-PYRAZOLOSPIROKETONE ACETYL-CoA CARBOXYLASE INHIBITORS |
| 07/25/2013 | US20130190332 Substituted Imidazo[1,2-a]pyrimidines and -pyridines |
| 07/25/2013 | US20130190330 Bisaryl-bonded aryltriazolones and use thereof |
| 07/25/2013 | US20130190320 Heterocyclic compounds and uses as anticancer agents |
| 07/25/2013 | US20130190312 Modulators of hec1 activity and methods therefor |
| 07/25/2013 | US20130190296 Compositions and methods for the treatment of disease associated with trp-p8 expression |
| 07/25/2013 | US20130190294 Compounds and methods for treating diabetes |